🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Philippe Conus

Hôpital de Cery

ORCID: 0000-0002-5832-1910

Also affiliated with Hôpital Orthopédique de la Suisse Romande, Siemens Healthcare (United States), University of Lausanne

MedicineArts and HumanitiesNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.711Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Development of the PSYCHS : Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS

Early Intervention in Psychiatry(2023)10.1111/eip.13457
Top 33%
0.607DataRank
Top 33%41 citations

Sophie Parker, Melissa Kerr, Barbara C. Walsh, S. Andrea Wijtenburg, Nicholas Prunier +68 more

Papers

Driven by 14 papers — median percentile 22. Top paper: “Development of the PSYCHS : Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS”.

Development of the PSYCHS : Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS

Early Intervention in Psychiatry(2023)10.1111/eip.13457
Top 33%
0.607DataRank
Top 33%41 citations

Sophie Parker, Melissa Kerr, Barbara C. Walsh, S. Andrea Wijtenburg, Nicholas Prunier +68 more

Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia Program

Schizophrenia Bulletin Open(2025)10.1093/schizbullopen/sgaf013
Top 78%
0.104DataRank
Top 78%1 citations

Amy Shalev, Lu Liu, Cari Jahraus, Monica Chu, Emily K. Farina +75 more

Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS

medRxiv(2023)10.1101/2023.04.29.23289226
N/A
0DataRank · unranked
21 citations

Sophie Parker, Melissa Kerr, Barbara C. Walsh, S. Andrea Wijtenburg, Nicholas Prunier +83 more

Bridging Structural MRI with Cognitive Function for Individual Level Classification of Early Psychosis via Deep Learning

Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition(2023)10.58530/2022/3926
N/A
0DataRank · unranked
0 citations

Chuan Zhou, Leiting Chen, Yu Deng, Martine Cleusix, Raoul Jenni +4 more

Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis

Schizophrenia Bulletin(2024)10.1093/schbul/sbae011
N/A
0DataRank · unranked
75 citations

Barnaby Nelson, Jean Addington, Kelly Allott, Alan Anticevic, Celso Arango +95 more

Matrix metalloproteinase 9 (MMP-9) activity, hippocampal extracellular free water, and cognitive deficits are associated with each other in early phase psychosis

Neuropsychopharmacology(2024)10.1038/s41386-024-01814-5
N/A
0DataRank · unranked
8 citations

Yasser Alemán‐Gómez, Kang Ik K. Cho, Ofer Pasternak, Martine Cleusix, Raoul Jenni +8 more

Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program

Schizophrenia(2025)10.1038/s41537-025-00599-w
N/A
0DataRank · unranked
10 citations

Ann Ee Ching, Yoonho Chung, Habiballah Rahimi-Eichi, Erlend Lane, Carsten Langholm +75 more

Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample

Schizophrenia(2025)10.1038/s41537-025-00578-1
N/A
0DataRank · unranked
8 citations

Walid Yassin, Luis Alameda, Tashrif Billah, Owen Borders, Kate Buccilli +93 more

The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program

Schizophrenia(2025)10.1038/s41537-025-00581-6
N/A
0DataRank · unranked
8 citations

Kang Ik K. Cho, Alan Anticevic, Nicolas R. Bolo, Sylvain Bouix, Dylan Campbell +82 more

The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures

Schizophrenia(2025)10.1038/s41537-025-00622-0
N/A
0DataRank · unranked
8 citations

Spero Nicholas, Brian J. Roach, Tashrif Billah, Suzie Lavoie, Thomas J. Whitford +95 more

Collecting language, speech acoustics, and facial expression to predict psychosis and other clinical outcomes: strategies from the AMP® SCZ initiative

Schizophrenia(2025)10.1038/s41537-025-00669-z
N/A
0DataRank · unranked
2 citations

Eduardo Castro, Carla Agurto, Einat Liebenthal, Michaela Ennis, Justin T. Baker +72 more

Baseline Clinical Characterization of Participants in the Accelerating Medicines Partnership Schizophrenia Program

Schizophrenia Bulletin Open(2025)10.1093/schizbullopen/sgaf012
Top 100%
0DataRank
Top 100%0 citations

Lu Liu, Monica Chu, Karl Jungert, Nora Penzel, Ofer Pasternak +77 more

Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS

UNC Libraries(2025)10.17615/2934-4s70
N/A
0DataRank · unranked
0 citations

Sylvain Bouix, Michael J. Coleman, Catalina Mourgues, Beau‐Luke Colton, Merete Nordentoft +68 more

Bridging structural MRI with cognitive function for individual level classification of early psychosis via deep learning

Frontiers in Psychiatry(2023)10.3389/fpsyt.2022.1075564
N/A
0DataRank · unranked
8 citations

Chuan Zhou, Leiting Chen, Yu Deng, Martine Cleusix, Raoul Jenni +4 more